This study aimed at revealing largely unknown proteome and phospho-proteome changes of early apoptotic events following treatment of human neuroblastoma SH-SY5Y control cells, stably overexpressing an empty vector, with apoptotic agent STS versus SH-SY5Y cells stably overexpressing PrPc exposed to the same apoptotic agent. This evidence concerns the gene PRNP and neuroblastoma.